Provided by Tiger Trade Technology Pte. Ltd.

Evaxion Biotech A/S

3.96
+0.14003.66%
Volume:9.62K
Turnover:37.63K
Market Cap:32.88M
PE:-3.29
High:3.96
Open:3.83
Low:3.83
Close:3.82
52wk High:12.15
52wk Low:1.20
Shares:8.30M
Float Shares:5.53M
Volume Ratio:0.82
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2027
EPS(LYR):-1.2027
ROE:-100.18%
ROA:-28.23%
PB:1.93
PE(LYR):-3.29

Loading ...

Evaxion a/S - Eligible for up to $592 Mln in Milestone Payments Associated With the Development of Evx-B3

THOMSON REUTERS
·
Dec 19, 2025

Evaxion Provides Update on Msd Collaboration - Retains Global Rights to Gonorrhea Vaccine Candidate Evx-B2

THOMSON REUTERS
·
Dec 19, 2025

Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2

GlobeNewswire
·
Dec 19, 2025

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live
·
Dec 16, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
Dec 12, 2025

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading

MT Newswires Live
·
Dec 11, 2025

European Equities Traded in the US as ADRs Little Changed in Monday Trading

MT Newswires Live
·
Dec 09, 2025

Evaxion Unveils Promising Preclinical Data for Off-the-Shelf AML Vaccine EVX-04

Reuters
·
Dec 08, 2025

Evaxion Unveils Promising Preclinical Data for AML Vaccine EVX-04 at ASH Meeting

Reuters
·
Dec 07, 2025

European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

MT Newswires Live
·
Nov 27, 2025

European Equities Traded in the US as American Depositary Receipts Little Changed in Monday Trading

MT Newswires Live
·
Nov 25, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down 3% for Week

MT Newswires Live
·
Nov 22, 2025

BRIEF-Evaxion A/S Prospectus Relates To Offer And Sale By Selling Shareholder000 Ordinary Shares

Reuters
·
Nov 21, 2025

Evaxion Biotech files to sell 38.45M ordinary shares for holders

TIPRANKS
·
Nov 21, 2025

Evaxion a/S: Prospectus Relates to Offer and Sale by Selling Shareholder of up to an Aggregate of 38,450,000 Ordinary Shares

THOMSON REUTERS
·
Nov 21, 2025

Evaxion Reports Positive Data for CMV Vaccine Program

TIPRANKS
·
Nov 20, 2025

Evaxion Announces Positive Data for Lead Antigens in Cytomegalovirus (Cmv) Vaccine Program Evx-V1

THOMSON REUTERS
·
Nov 20, 2025

Evaxion Unveils Novel AI-Discovered Antigens Showing Protective Effects in CMV Vaccine Program

Reuters
·
Nov 20, 2025

Evaxion Biotech Q3 Basic EPS USD 0.01

Reuters
·
Nov 20, 2025

Evaxion Biotech Increases Share Capital Following Warrant Exercise

TIPRANKS
·
Nov 19, 2025